Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative Study

In our study cohort, AS is not inferior to PI in patients with SRM suspicious for renal cell carcinoma. The difference in OS between AS and PI is most likely attributable to the increased risk of death from competing causes among AS patients. A priori definitions of progression, including growth rate, should be reconsidered.

Authors

Institutions

Publication Details

Journal
The Journal of Urology
Published
2025-04-22
DOI
https://doi.org/10.1097/ju.0000000000004583
Citations
4
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
6.07
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative Study

Thomas J. Guzzo, Peter Chang, Khalid Y. Alkhatib, Ridwan Alam et al.
4 citations
The Journal of Urology
Renal cell carcinoma treatment
6.07
article

Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative Study

Thomas J. Guzzo, Peter Chang, Khalid Y. Alkhatib, Ridwan Alam, Mohamad E. Allaf, Phillip M. Pierorazio, Nirmish Singla, Andrew A. Wagner, Joseph Cheaib, Tina Wlajnitz, James M. McKiernan, Hiten D. Patel, Christian P. Pavlovich, Maximilian Pallauf
article en
4 citations

Abstract

In our study cohort, AS is not inferior to PI in patients with SRM suspicious for renal cell carcinoma. The difference in OS between AS and PI is most likely attributable to the increased risk of death from competing causes among AS patients. A priori definitions of progression, including growth rate, should be reconsidered.

The Journal of UrologyVol. 214(2)
Northwestern University (US), Beth Israel Deaconess Medical Center (US), Johns Hopkins University (US), Paracelsus Medical University (AT), Columbia University Irving Medical Center (US), Johns Hopkins Medicine (US), Northwestern University (PH), Penn Center for AIDS Research (US), Northwestern Medicine (US), University of Pennsylvania (US)
Openalex Percentile: Top 4%
Renal cell carcinoma treatment
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.